statistiche ricercatore

Continente	#
NA - Nord America	606
EU - Europa	586
AS - Asia	456
SA - Sud America	71
Continente sconosciuto - Info sul continente non disponibili	23
AF - Africa	11
Totale	1.753

Nazione	#
US - Stati Uniti d'America	585
RU - Federazione Russa	312
SG - Singapore	179
CN - Cina	106
IT - Italia	73
BR - Brasile	54
GB - Regno Unito	45
VN - Vietnam	45
DE - Germania	42
HK - Hong Kong	40
BD - Bangladesh	31
SE - Svezia	26
IE - Irlanda	25
FI - Finlandia	22
KR - Corea	20
FR - Francia	15
CA - Canada	13
AR - Argentina	8
IN - India	6
MX - Messico	5
PL - Polonia	5
JP - Giappone	4
AT - Austria	3
CO - Colombia	3
ES - Italia	3
ID - Indonesia	3
PK - Pakistan	3
SA - Arabia Saudita	3
TR - Turchia	3
UA - Ucraina	3
AZ - Azerbaigian	2
BJ - Benin	2
IR - Iran	2
JM - Giamaica	2
JO - Giordania	2
NG - Nigeria	2
NL - Olanda	2
PY - Paraguay	2
TG - Togo	2
UZ - Uzbekistan	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
CH - Svizzera	1
CL - Cile	1
DZ - Algeria	1
EC - Ecuador	1
HR - Croazia	1
IQ - Iraq	1
IS - Islanda	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
RO - Romania	1
RS - Serbia	1
SI - Slovenia	1
SL - Sierra Leone	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.731

Nome	#
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass	206
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease.	175
WS19.6 N 2 -MBW in CF patients with chronic lung bacterial colonizations	165
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation.	163
Age at menarche in girls with cystic fibrosis and asthma	159
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells	143
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis	141
Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial	131
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation	129
Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial	119
Delayed age at menarche in chronic respiratory diseases	118
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic	104
Totale	1.753

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	20	0	0	0	0	2	0	0	2	3	2	2	9
2022/2023	108	6	10	12	14	8	24	4	5	16	2	7	0
2023/2024	150	4	12	14	19	17	23	4	17	0	10	22	8
2024/2025	310	12	8	8	60	13	12	14	15	60	15	36	57
2025/2026	980	58	44	84	156	270	54	68	42	64	58	48	34
2026/2027	27	6	21	0	0	0	0	0	0	0	0	0	0
Totale													1.753

CATALOGO DEI PRODOTTI DELLA RICERCA